Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 21778 [2012-8682]

Download as PDF 21778 Federal Register / Vol. 77, No. 70 / Wednesday, April 11, 2012 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) Dated: April 5, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. The meeting announced below concerns Development and Testing of a Clinic-Based Intervention to Increase Dual Protection against Unintended Pregnancy and STDs among High Risk Female Teens, FOA DP12–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Dates: Time and Date: 11 a.m.–5 p.m., May 8, 2012 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Development and Testing of a Clinic-Based Intervention to Increase Dual Protection against Unintended Pregnancy and STDs among High Risk Female Teens, FOA DP12–001, initial review.’’ Contact Person For More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–46, Atlanta, Georgia 30341, Telephone: (770) 488–3585. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 1, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–8660 Filed 4–10–12; 8:45 am] wreier-aviles on DSK5TPTVN1PROD with NOTICES BILLING CODE 4163–18–P In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: TIME AND DATE: 8 a.m.–2:50 p.m., May 2, 2012. PLACE: CDC, Global Communications Center, 1600 Clifton Road NE., Building 19, Auditorium B3, Atlanta, Georgia 30333. STATUS: Open to the public, limited only by the space available. PURPOSE: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. MATTERS TO BE CONSIDERED: The meeting will include reports from the BSC OID working groups, brief updates from the infectious disease national centers, and focused discussions on CDC’s safe water activities, immunization infrastructure, and sexually transmitted diseases. Agenda items are subject to change as priorities dictate. CONTACT PERSON FOR MORE INFORMATION: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639– 4461. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the [FR Doc. 2012–8682 Filed 4–10–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request Title: Uniform Project Description (UPD) Program Narrative Format for Discretionary Grant Application Forms. OMB No.: 0970–0139 Description: The proposed information collection would extend the Administration for Children and Families’ (ACF) Uniform Project Description (UPD). The UPD provides a uniform grant application format for applicants to submit project information in response to ACF discretionary funding opportunity announcements. ACF uses this information, along with other OMB-approved information collections (Standard Forms), to evaluate and rank applications. Use of the UPD helps to protect the integrity of ACF’s award selection process. All ACF discretionary grant programs are required to use this application format. The application consists of general information and instructions; the Standard Form 424 series, which requests basic information, budget information, and assurances; the Project Description that requests the applicant to describe how program objectives will be achieved; and other assurances and certifications. Guidance for the content of information requested in the Project Description is found in OMB Circular A–102; 2 CFR, Part 215; 2 CFR, Part 225; 2 CFR, Part 230; 45 CFR, Part 74; and 45 CFR, Part 92. Respondents: Applicants to ACF Discretionary Funding Opportunity Announcements. ANNUAL BURDEN ESTIMATES Instrument Number of respondents Number of responses per respondent Average burden hours per response Total burden hours ACF Uniform Project Description ..................................................................... 5,500 1 60 330,000 VerDate Mar<15>2010 15:14 Apr 10, 2012 Jkt 226001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\11APN1.SGM 11APN1

Agencies

[Federal Register Volume 77, Number 70 (Wednesday, April 11, 2012)]
[Notices]
[Page 21778]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-8682]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Infectious Diseases 
(BSC, OID)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

TIME AND DATE: 8 a.m.-2:50 p.m., May 2, 2012.

PLACE: CDC, Global Communications Center, 1600 Clifton Road NE., 
Building 19, Auditorium B3, Atlanta, Georgia 30333.

STATUS: Open to the public, limited only by the space available.

PURPOSE: The BSC, OID, provides advice and guidance to the Secretary, 
Department of Health and Human Services; the Director, CDC; the 
Director, OID; and the Directors of the National Center for 
Immunization and Respiratory Diseases, the National Center for Emerging 
and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: 
strategies, goals, and priorities for programs; research within the 
national centers; and overall strategic direction and focus of OID and 
the national centers.

MATTERS TO BE CONSIDERED: The meeting will include reports from the BSC 
OID working groups, brief updates from the infectious disease national 
centers, and focused discussions on CDC's safe water activities, 
immunization infrastructure, and sexually transmitted diseases.
    Agenda items are subject to change as priorities dictate.

CONTACT PERSON FOR MORE INFORMATION: Robin Moseley, M.A.T., Designated 
Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, 
Atlanta, Georgia 30333, Telephone: (404) 639-4461.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: April 5, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-8682 Filed 4-10-12; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.